BMS-538203
CAS No. 543730-41-2
BMS-538203( BMS538203 | BMS 538203 )
Catalog No. M14950 CAS No. 543730-41-2
A chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120,
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1053 | Get Quote |
|
50MG | 2142 | Get Quote |
|
100MG | 2790 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBMS-538203
-
NoteResearch use only, not for human use.
-
Brief DescriptionA chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120,
-
DescriptionA chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS538203 | BMS 538203
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number543730-41-2
-
Formula Weight269.2258
-
Molecular FormulaC12H12FNO5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 54 mg/mL
-
SMILESO=C(O)/C(O)=C/C(N(CC1=CC=C(F)C=C1)OC)=O
-
Chemical Name2-Butenoic acid, 4-[[(4-fluorophenyl)methyl]methoxyamino]-2-hydroxy-4-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nowicka-Sans B, et al. Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507.
molnova catalog
related products
-
Enfuvirtide
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.
-
BNM-III-170
BNM-III-170 is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo.
-
Navuridine
Navuridine is an oral active inhibitor of HIV reverse transcriptase with a relatively short half-life.